Serenus.AI ^Company

Serenus.AI specializes in the development of advanced Generative AI technologies that empower medical decisions at critical medical crossroads on patients' pathways, saving lives and valuable resources. Our flagship product is the first (registered patent and 4 patents pending) clinically objective, Generative AI, automated case-by-case system to improve referrals before medical procedures and treatments, while prioritizing patients' waiting lists. Serenus.AI advances the quality and equality of healthcare delivery, saves valuable resources, and boosts patients', physicians', and payers' satisfaction across the board.
Among the Serenus.AI team are top medical experts from various medical fields and machine learning specialists. The innovative solution was already validated in practice and the company is currently active in Europe and the US with leading stakeholders in the healthcare field. The company received grants from 4 government entities in Israel who validated its innovation and technology, including the Ministry of Health, Ministry of Economics, the Innovation Authority, and the Bilateral US-Israel Bird Award.

Please also see articles about our solution:

https://www.extra-mag.co.il/making-an-informed-decision/
https://www.yorkshireeveningpost.co.uk/health/can-smart-robot-match-surgeons-skills-leeds-researchers-will-find-out-2005357
https://datarootlabs.com/blog/ai-in-healthcare-how-ai-startups-disrupt-the-healthcare-industry